The pain management drugs and devices market covers pharmaceuticals, medical devices, and analgesic solutions used for managing different types of pain in patients. This includes both acute and chronic pain conditions across surgical, cancer, neuropathic, musculoskeletal and other indications.
According to Inkwood Research, the global pain management drugs and devices market is forecasted to grow with a CAGR of 3.70%, between 2024-2032.
The pain management industry is undergoing steady growth, boosted by the rising prevalence of chronic pain disorders, geriatric populations, demand for minimally invasive surgeries, and technological advancements in pain management devices. Neurostimulation devices, ablation devices, analgesic pumps, and drug delivery systems are key devices used in pain management.
Developments in Non-Opioid Pain Management
- The opioid crisis has put focus on developing abuse-deterrent formulations and non-opioid medications for pain relief.
- Common drug classes include NSAIDs, anticonvulsants, antidepressants, opioids, anesthetics, and cannabinoids. The market highlight features innovative non-opioid drugs belonging to new classes of analgesics, such as monoclonal antibodies, receptor antagonists, and nerve growth factors.
- Pfizer is a leading player in the pain management drugs market, with a diverse portfolio of branded and generic pain medications. One of its flagship drugs is Lyrica (pregabalin), which is an anticonvulsant used to treat neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury, fibromyalgia, and other conditions.
- The SCS-1000 spinal cord stimulator by Medtronic is an implantable neurostimulation device that uses mild electrical signals to alter pain signals and provide relief. It can treat intractable pain in the trunk and limbs and has programmable stimulation settings.
Get CUSTOMIZED insights fine-tuned to match your unique requirements delivered right to your inbox!
Pain Management Drugs and Devices Market: Neurostimulation Applications & Emerging Practices
Neurostimulation solutions, encompassing both invasive spinal cord stimulators and non-invasive transcutaneous electrical nerve stimulation (TENS) devices, are experiencing notable progress. Ongoing advancements in implantable systems are integral in the expansion of neurostimulation devices. Additionally, the development of programmable stimulation settings enhances their utilization in effectively managing chronic intractable pain.
On that note, let’s take a closer look at the emerging practices and approaches in pain management drugs & devices –
- Ablation devices using thermal energy sources like radiofrequency, cryoablation, and ultrasound are incorporated today to target specific nerves and provide lasting pain relief.
- Wearable pain relief devices like Quell utilize transcutaneous electrical nerve stimulation (TENS) to effectively block pain signals.
- Programmable pumps in implantable intrathecal drug delivery systems dispense analgesic drugs directly into the spinal canal for pain relief.
- Innovative drug-eluting pain patches provide ongoing transdermal drug delivery by permeating through the skin.
Stay up-to-date with what’s trending in the global pain management drugs and devices market
Artificial intelligence (AI) and machine learning stand as modern technologies with the potential to reshape pain diagnosis and treatment in the healthcare industry. These innovations enable the analysis of data collected from wearable devices and smartphone apps to accurately gauge pain levels and predict potential flare-ups.
Additionally, AI facilitates the development of personalized pain management strategies, leveraging individual patient genetics and biomarkers for enhanced treatment effectiveness.
As technical progression redefines the sphere of pain management drugs and devices globally, the focus on enhancing therapeutic efficacy and elevating overall patient well-being is expected to drive pain management drugs and devices market growth over the forecasting years.
By Kiran Raut
FAQ
The major drug classes used for pain management include non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, opioids such as codeine and oxycodone, anticonvulsants like gabapentin, antidepressants such as duloxetine, anesthetics including lidocaine, and cannabinoids like medical marijuana.
Common medical devices used for pain management are neurostimulators like spinal cord stimulators and transcutaneous electrical nerve stimulation (TENS) devices, ablation devices employing thermal energy sources, analgesic infusion pumps delivering drugs intrathecally or to targeted sites, and transdermal drug delivery systems including pain relief patches.
The major risks associated with opioids include dependence, addiction, overdose, and death. Other side effects include constipation, nausea, drowsiness, slowed breathing, and impaired mental functioning. Prolonged opioid use can lead to increased pain sensitivity, known as hyperalgesia.